How would that be AT? TIS is not even in the XAO, let alone the 300, so it would not pass institutional filters.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025